Ebang International Holdings Inc. (NASDAQ: EBON)
Ebang International Holdigns Inc. is a penny stock that we have discussed numerous times in the past few months. If you’re unfamiliar, Ebang is a company that engages in the development of integrated circuit chips and Bitcoin mining machines. It also provides mining machine hosting services that allow customers to operate them remotely. Its products are sold under the EBANG and Ebit brand names.
On October 1st, Ebang released its unaudited financial results for the first six months of the fiscal year 2021. The company’s total computing power sold in the first six months was 0.8 million Thash/s. This means that its total computing power sold went up by 220% year over year. Its net revenue went up 65.69% year over year to $18.30 as well. As a result, Ebang was able to significantly reduce its net loss. These numbers are all very positive for the company, and illustrate why the company is growing so much right now.
On October 26th, the company’s stock price is up 1.43%. With this in mind, will EBON be on your list of penny stocks to watch?
SOS Limited (NYSE: SOS)
SOS Limited is another penny stock that we have discussed frequently, with big ties to cryptocurrency. This company offers marketing data, tech, and solutions for insurance companies, EMS, and insurance info portals. It runs the SOS cloud emergency service software to help with medical rescue, auto rescue, financial rescue, and more.
On October 18th, SOS announced the lease of a new office in Manhattan, New York as its North American headquarters. The company has been actively trying to expand its global footprint, and this new office shows progress toward this goal. This facility will accommodate its business development, management, and blockchain R&D activities in North America.
In the last month, SOS stock has gone up in the market. Noting this new advancement, will SOS be on your penny stock watchlist this coming month?
Geron Corporation (NASDAQ: GERN)
Geron Corporation is a biotech penny stock that managed to push up by around 2.7% today and over 6% in the last five days. This company makes products for hematologic myeloid malignancies. The company focuses on the development and commercialization aspects of these therapeutics. Its Imetelstat product is in Phase 3 clinical trials to inhibit the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies to treat myelodysplastic syndromes.
On October 25th, the company announced that imetelstat has been granted an Innovation Passport which is the first prescribed entry point to the Innovative Licensing and Access Pathway launched in the U.K by the MHRA. This is a significant landmark for Geron and allows the company a 150-day accelerated assessment and rolling review of a Marketing Authorization Application.
With all of this in mind, does GERN stock deserve a spot on your list of penny stocks to watch?
This article originally ran on pennystocks.com.